Why is Emcure Pharma falling/rising?

As of 15-Oct, Emcure Pharmaceuticals Ltd is experiencing a price increase, currently at 1,365.60, reflecting a rise of 26.0 or 1.94%. Today's price summary indicates that the stock has outperformed its sector by 1.86% and has shown a trend reversal after two consecutive days of decline, reaching an intraday high of Rs 1372.15. Despite this positive movement, the stock's performance over the past week shows a decline of 1.30%, and it has underperformed the benchmark Sensex over the year-to-date and one-year periods, with declines of 5.03% and 7.61%, respectively. However, the company has demonstrated strong financial health, with a high return on capital employed (ROCE) of 20.99%, a low debt to EBITDA ratio of 0.53, and positive results for the last four consecutive quarters, which may contribute to investor confidence.
In the broader market context, the Sensex has increased by 1.02% over the past week, while Emcure's performance has been slightly negative, indicating that the stock is not keeping pace with the benchmark in the short term. However, the stock's recent upward movement today suggests a potential recovery, even as investor participation has decreased, with delivery volume falling by 15.1% against the five-day average. This decline in participation could indicate caution among investors despite the company's solid financial metrics, which may lead to a more cautious outlook moving forward.